Oncology
Howard Burris, M.D.
President and Chief Medical Officer, Sarah Cannon Research Institute
Nashville, TN
Dr. Howard A. "Skip" Burris III established the first community-based phase I drug development program in 1997, which became Sarah Cannon Research Institute. As president and chief medical officer of SCRI, he leads one of the world's foremost oncology research organizations. His career has focused on first-in-human therapies and novel drug development. He served as President of the American Society of Clinical Oncology (ASCO) in 2019-2020 and has been recognized as a Giant of Cancer Care by OncL
Credentials
Board Certifications
- Internal Medicine
- Medical Oncology
Education & Training
- BS: United States Military Academy at West Point
- MD: University of South Alabama College of Medicine
- Residency: Brooke Army Medical Center (Internal Medicine)
- Fellowship: Brooke Army Medical Center (Hematology and Medical Oncology)
Peer Recognition
- Healthgrades — Healthgrades Honor Roll
Clinical Focus
Subspecialties
Medical Oncology
Conditions & Treatments
Clinical Trials & Drug Development
Practice Details
Hospital Affiliations
- Williamson Medical Center
- TriStar Centennial Medical Center